Bart Spee - Utrecht University - LifeTec Group
LifeTec Group News

New models to predict liver toxicity

"Many new pharmaceuticals turn out to be toxic, even after they have been released to the market", says Bart Spee. Together with his fellow researchers he's aiming to develop specialized liver cells, which could be used for purposes such as testing new medication.

Society deserves meaningful and affordable medical solutions. It's our mission to make it happen.
Ambitious and passionate professionals who devote themselves to fulfill your research needs and aims with pragmatic solutions.
Ways LifeTec Group can help you:
  • Preclinical Contract Research
    Focus is on the meaning of the study results, at the same time paving the way for better preclinical processes.
  • Tech & Training
    Enable ways of Researching, Developing and Training that weren't deemed possible before.
  • Acceleration of medtech innovation
    Help medtech innovators turn good ideas into great medical solutions.
  • Consultancy
    Faster lead times, and thus lower costs, as well as broad, well-documented insights.
updates.
  • Bart Spee - Utrecht University - LifeTec Group
    Lifetec news

    New models to predict liver toxicity

    "Many new pharmaceuticals turn out to be toxic, even after they have been released to the market", says Bart Spee. Together with his fellow researchers he's aiming to develop specialized liver cells, which could be used for purposes such as testing new medication.

  • Arend de Weger, Noemi Vanerio, Marco Stijnen
    Lifetec news

    Marco looks back on ASAIO Chicago

    Just returned from the trip to Chicago to visit the 63rd edition of the ASAIO conference, LifeTec Group's R&D Director Marco Stijnen looks back on this event and shares his thoughts. 

  • LifeTec Group | CSI Frankfurt 2017
    Tech & Training news

    Meet us in Frankfurt

    CSI Frankfurt, June 28 to July 1, will provide a deep dive into major topics in catheter-based therapy of congenital, structural and valvar heart disease. So goes the opening line on the CSI website and LifeTec Group is excited to pitch in.

Director of Operations

Lars Mulder

Director R&D

Marco Stijnen

R&D Engineer

Luca Paroni

R&D Engineer

Nicky de Jonge

R&D Engineer

Loes van der Donk

Project Leader

Linda Kock

Medical Director

Bas de Mol

R&D Engineer

Marcel Wijlaars

CEO

Jurgen de Hart

R&D Engineer

Benjamin Kappler

Senior Medical Biotechnologist

Carmelina Angotti

Senior Research Engineer

Sjoerd van Tuijl

Biochemical Engineer

Melanie Krüger

R&D Engineer

Noemi Vanerio

Marketing Director

Toine Nagel

Office Manager

Janneke Cuijpers

©2017 LifeTecGroup.  Legal  Credits